MassDevice Archives - Page 408 of 587 - Medical Design Sourcing

Philips enters partnership for stroke tech, enrolls first patient in stroke study

Royal Philips (NYSE:PHG) announced a strategic partnership and a clinical trial milestone for its expanded stroke treatment capabilities.

Amsterdam-based Philips yesterday confirmed a strategic partnership with medtech stroke care company Nico.Lab that will use Philips’ Azurion image-guided therapy system to advance stroke treatment. Additionally, the company announced the enrollment of the first patient in a global stroke study.

In the collaboration, Nico.Lab offers its StrokeViewer cloud-based, end-to-end artificial intelligence-based stroke triage and management solution that seeks to improve patient outcomes by optimizing the stroke workflow.

The platform analyzes CT scan data with AI and automatically detects large vessel occlusion (LVO) and its location before sharing the analysis with physicians at primary stroke centers and intervention centers where the patient eventually receives treatment.

Philips said in a news release that its r…

Abbott to sell its STARLIMS informatics product suite

Global investment firm Francisco Partners announced today that it has agreed to acquire Abbott’s STARLIMS informatics product suite for an undisclosed amount.

Companies in the life sciences, pharma and biotech, chemical and refining, food and beverage, manufacturing, environmental, public health and forensics sectors have used the STARLIMS suite of products for more than 35 years.

The software helps organizations to manage the collection, processing, storage, retrieval and analysis of information generated in laboratories. It’s meant to improve quality and safety throughout the entire product lifecycle, starting with R&D.

The software boasts 1,100 customers across 60 countries.

“The STARLIMS technology is a leader in data and workflow management for laboratories across the globe. With the constantly changing landscape of quality manufacturing coupled with substantial industry tailwinds, we believe the business is well positioned fo…

Osso VR raises $27M for its immersive surgical training

Osso VR today said it secured $27 million in Series B funding for its surgical training technology.

The funding round was led by GSR Ventures, with participation from Signalfire, Kaiser Permanente Ventures, OCA Ventures, Scrum Ventures, Leslie Ventures and Anorak Ventures.

San Francisco-based Osso VR designed its surgical training technology to provide on-demand, educational experiences that are repeatable and measurable to help surgeons with surgical techniques and technologies.

“Osso VR is positioned to transform how surgeons are trained on new devices and surgical procedures,” said Sunny Kumar, a partner at GSR Ventures. “The Osso platform’s level of immersion provides an experience that mirrors the operating room in a manner more efficient, more accessible, and more effective than any surgical training platform that’s come before.”

Osso VR’s platform has visual fidelity and is available in multiple lan…

How bioengineers tackled the leaky mask problem

Researchers from Harvard and MIT have formed a company to mass-produce a more effective three-ply mask for everyday use.

The Ultra Fit mask’s design improvements include extending the nose wire all around the mask and making the ear loops adjustable. [Image courtesy of Katharos Labs]Anyone who wears glasses knows that the ubiquitous blue pleated mask leaks vapor upward, despite the wire designed to conform to the shape of the nose.

Less obvious is the leakage from the mask’s sides and bottom, which a sneeze or cough can increase many times over. While three-ply disposable masks provide some protection for the wearer and those around them, they could be much safer for all.

That’s the conclusion of a team of researchers from the Brigham and Women’s Hospital, Harvard University, Massachusetts Institute of Technology (MIT) and Massachusetts General Hospital. They set out to develop a more practical everyday mask that could be mass-produced and…

Smith+Nephew launches Fast-Fix Flex meniscal repair system

[Image from Smith+Nephew]Smith+Nephew (LSE:SN;NYSE:SNN) announced today that it launched the Fast-Fix Flex meniscal repair system.

London-based Smith+Nephew touts its Fast-Fix Flex meniscal repair system as the only device to offer a surgeon-guided, bendable needle and shaft to provide access to all zones of the meniscus, resulting in long-term benefits to the patient, according to a news release.

The company’s new Fast-Fix Flex system uses an all-inside approach in an effort to eliminate the need for further incisions, reduce the risk of neurovascular injury and provide procedural efficiency to support faster operating times.

Smith+Nephew said the product, which is now commercially available in the U.S. and other select countries, includes the added ability to bend both the needle and the shaft to enable surgeons access to the mid-body and anterior zones that weren’t accessible for previous Fast-Fix devices.

“The launch of Fast-F…

Conformis, Stryker settle in Wright Medical patent infringement litigation

Conformis (NSDQ:CFMS) announced today that it settled with Stryker (NYSE:SYK) to resolve patent litigation involving Wright Medical.

Billerica, Mass.-based Conformis said in a news release that Stryker, which acquired Wright Medical in November 2020, will make a one-time payment to Conformis and be granted a non-exclusive license with respect to certain Conformis patients.

On April 24, 2020, Conformis filed a lawsuit against Wright in the U.S. District Court for the District of Delaware, alleging in an amended complaint that Wright’s multiple lives of patient-specific shoulder instruments and the implant components used in conjunction with those implants infringed certain Conformis patents.

“We are pleased to have resolved all of the ongoing patent litigation related to the Wright Medical dispute,” Conformis president & CEO Mark Augusti said in the release. “The settlement once again highlights the strength and value of our intellectual propert…

Surmodics acquires Vetex Medical and its mechanical thrombectomy catheter

Surmodics (NSDQ:SRDX) announced that it acquired Vetex Medical, a developer and manufacturer of venous clot removal solutions.

Galway, Ireland-based Vetex Medical offers Surmodics a second FDA-cleared device for its thrombectomy portfolio with the ReVene thrombectomy catheter. Vetex designed ReVene to remove large, mixed-morphology blood clots commonly found with venous thromboembolism (VTE).

Get the full story at our sister site, Medical Tubing & Extrusion.

Explorer Surgical expands offerings into robotic surgery space

Explorer Surgical announced today that will expand its cloud-based digital platform into the robotic surgery space.

As a result of the foray into surgical robotics, medical robotics companies will now be able to leverage the Explorer Live digital platform and procedural playbook, video capabilities and data collection offerings to improve workflow and performance.

Get the full story at our sister site, Medical Design & Outsourcing.

Siemens Healthineers wins FDA clearance for Magnetom Free.Max MR scanner

Siemens Healthineers (ETR:SHL) announced today that it received FDA clearance for the Magnetom Free.Max magnetic resonance (MR) scanner.

Malvern, Pa.-based Siemens Healthineers developed the High-V MR scanner to combine a 0.55 Tesla field strength with deep learning technologies and advanced image processing to broaden the range of MR clinical applications, according to a news release.

The company touts the Magnetom Free.Max as the first and only 80 cm wide-bore system available, while the platform also facilitates MR scanning for extremely obese and claustrophobic patients.

Siemens Healthineers said that, at 3.5 tons and less than 80 inches tall, the MR scanner is the “most lightweight, compact whole-body scanner” the company has ever offered, with the reduced size permitting installation with minimal structural modifications. It uses less than 1 liter of helium, compared to the standard of several hundred liters, the company added.

T…

Fresenius Kabi launches Simplist fentanyl citrate injection

[Image from Fresenius Kabi]Fresenius Kabi announced today that it initiated the U.S. introduction of a fentanyl citrate injection in the Simplist pre-filled syringe.

Lake Zurich, Ill.-based Fresenius Kabi’s proprietary Simplist ready-to-administer prefilled syringe offers the fentanyl citrate injection at 50 mcg per 1 mL in an effort to reduce waste and diversion while ensuring the safe delivery of medication.

Get the full story at our sister site, Drug Delivery Business News.

Medtronic issues Class I recall of some angiographic guidewires

The FDA classified the recall of some angiographic guidewires made by Medtronic (NYSE:MDT) as Class I, the most serious kind.

Medtronic’s angiographic guidewire component affected by the recall helps place catheters into the vasculature during angiography or other interventional procedures.

According to an FDA notice, the recall occurred because devices were not sterilized before being shipped directly to hospitals. Should patients experience exposure to the non-sterile device, serious adverse events including infection, sepsis and death may occur.

No injuries or deaths have been reported in relation to the issue, which has been the subject of two complaints. The FDA notice says there is potential for underreporting as physicians may not have been aware that the devices were non-sterile.

Medtronic initiated the recall on May 4, 2021, and it encompasses guidewires distributed between Nov. 23, 2007, and March 29, 2021. In total, the company re…

MedTech 100 roundup: New all-time best reached

Once again, the medtech industry has soared to new heights, eclipsing its all-time best performance by the tiniest of margins.

MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished the week (July 2) at 114.59 points, coming in just 0.01 points ahead of the 114.58-point mark set in April — previously the industry’s all-time best performance.

The new high mark also represents a 1% rise from the 113.42-point total reached last week (June 25). The industry took a strong June into July, rising nearly 7% over the past four weeks.

Having overcome some recent setbacks, medtech’s performance continues to reflect an overall rebound from the struggles brought on by the COVID-19 pandemic, too. The industry has registered a 24.1% rise from the pre-pandemic high of 92.32 (set on Feb. 19, 2020), plus an 84.4% increase from the mid-pandemic low of 62.13 (March 23, 2020).

The positive movement in medtech …